Back to Browse Journals » International Journal of Women's Health » Volume 2

Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions

Authors Deirdre R Pachman, Jason M Jones, Charles L Loprinzi

Published Date May 2010 Volume 2010:2 Pages 123—135

DOI http://dx.doi.org/10.2147/IJWH.S7721

Published 14 May 2010

Deirdre R Pachman1, Jason M Jones1, Charles L Loprinzi2

1Internal Medicine, Mayo Clinic, Rochester, MN, USA; 2Medical Oncology, Mayo Clinic, Rochester, MN, USA

Abstract: Hot flashes are one of the most common and distressing symptoms associated with menopause, occurring in more than 75% of postmenopausal women. They are especially problematic in breast cancer patients since some breast cancer therapies can induce hot flashes. For mild hot flashes, it is proposed that behavioral modifications are the first step in management. Hormonal therapies, including estrogens and progestogens, are the most well known effective agents in relieving hot flashes; however, the safety of these agents is controversial. There is an increasing amount of literature on nonhormonal agents for the treatment of hot flashes. The most promising data regard newer antidepressant agents such as venlafaxine, which reduces hot flashes by about 60%. Gabapentin is another nonhormonal agent that is effective in reducing hot flashes. While many complimentary therapies, including phytoestrogens, black cohosh, and dehydroepiandrosterone, have been explored for the treatment of hot flashes; none can be recommended at this time. Furthermore, there is a lack of strong evidence to support exercise, yoga, or relaxation for the treatment of hot flashes. Paced respirations and hypnosis appear to be promising enough to warrant further investigation. Another promising nonpharmacological therapy, currently under investigation, involves a stellate ganglion block.
Keywords: vasomotor symptoms, hot flashes, menopause, therapy

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Targeted hyperthermia after selective embolization with ferromagnetic nanoparticles in a VX2 rabbit liver tumor model

Sun HL, Xu LF, Fan TY, Zhang HZ, Wang XD, Zhou YF, Yang RJ

International Journal of Nanomedicine 2013, 8:3795-3804

Published Date: 2 October 2013

Evaluation and management of acute abdominal pain in the emergency department

Macaluso CR, McNamara RM

International Journal of General Medicine 2012, 5:789-797

Published Date: 26 September 2012

Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine

Umland EM, Falconieri L

International Journal of Women's Health 2012, 4:305-319

Published Date: 5 July 2012

Insight into 144 patients with ocular vascular events during VEGF antagonist injections

Mansour AM, Shahin M, Kofoed PK, Parodi MB, Shami M, Schwartz SG

Clinical Ophthalmology 2012, 6:343-363

Published Date: 6 March 2012

Functionalization of single-walled carbon nanotubes and their binding to cancer cells

Madani SY, Tan A, Dwek M, Seifalian AM

International Journal of Nanomedicine 2012, 7:905-914

Published Date: 22 February 2012

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I

Neuropsychiatric Disease and Treatment 2012, 8:85-93

Published Date: 9 February 2012

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease

Stricker RB, DeLong AK, Green CL, Savely VR, Chamallas SN, Johnson L

International Journal of General Medicine 2011, 4:639-646

Published Date: 6 September 2011

Primary omental hydatid cyst

Halil Alis, Selin Kapan, Osman Öner, Aliye Soylu, Kemal Dolay, et al

International Medical Case Reports Journal 2009, 2:7-10

Published Date: 26 February 2009